International Network of VENous Thromboembolism Clinical Research Networks


Site News
« Back to listings

INVENT endorsed RENOVE study (REduced dose versus full dose of direct oral anticoagulant after  uNprOvoked Venous thromboembolism) has now been registered in ClinicalTrials database and approved by the Drug French Agency and national ethics board! The study is expected to start on October 30, 2017 and is looking for potential sites and investigators. Click here to learn more about the study and how to participate!


There are currently no comments.

Log in to post a comment.


* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.